arrow_back Back to App

Doubled funding and tax relief for substance use disorder treatment staff.

This act reauthorizes and doubles the funding for the loan repayment program aimed at professionals treating substance use disorders. Crucially, these loan repayments will no longer be considered taxable income, making the program significantly more appealing to doctors and therapists. The goal is to increase the number of available specialists and improve access to care for those struggling with addiction.
Key points
Funding for the loan repayment program for substance use disorder treatment staff is doubled from $25 million to $50 million annually for fiscal years 2024 through 2028.
Loan repayment amounts received by professionals under this program will be exempt from federal income tax.
The tax exemption provides a major financial incentive to attract and retain more healthcare workers in the critical field of addiction treatment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_3200
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Process start date: 2023-11-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_3200.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-11-02.

What are the main provisions?

Key points include:

  • Funding for the loan repayment program for substance use disorder treatment staff is doubled from $25 million to $50 million annually for fiscal years 2024 through 2028.
  • Loan repayment amounts received by professionals under this program will be exempt from federal income tax.
  • The tax exemption provides a major financial incentive to attract and retain more healthcare workers in the critical field of addiction treatment.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hassan, Margaret Wood [D-NH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Taxes